Talius has been selected as one of ten Brisbane health innovators for the 2025/26 MedTech Global Accelerator, a program designed to help pioneering companies fast-track international growth and investment.
Delivered by Brisbane Economic Development Agency (BEDA) in partnership with US-based Life Science Nation, the six-month program supports high-potential medical and digital health ventures as they prepare to engage with global investors, partners, and markets. It culminates in January 2026 at J.P. Morgan Healthcare Week in San Francisco, the world’s largest healthcare capital marketplace.
At Talius, we believe better health outcomes start with better visibility. Our platform connects clinicians, patients, and care teams through secure, real-time data—enabling faster, more informed decision-making at every step of the care journey. We’re proud to be part of a program that recognises the power of digital health to transform systems of care and save lives.
Joining the MedTech Global Accelerator marks a significant milestone in our mission to scale globally and support more clinicians with tools that put critical health insights at their fingertips. With Brisbane’s health sector forecast to grow 36 percent by 2031, we’re excited to help shape the city’s future as a global leader in healthcare innovation.
Read the full ASX announcement here.
To learn how Talius can support your organisation, get in touch with our team to speak with a representative.